Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chang'an granules for diarrhea-predominant irritable bowel syndrome (liver stagnation and spleen deficiency pattern)
CTR20132565Phase 2Completed
- Sponsor
- SHUTCM Yuanchuang Technology
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Changan Granules in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by SHUTCM Yuanchuang Technology. Started Mar 2014; status: completed.
02
Drugs
Changan Granules
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20132565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132565.